DZ964A1 - Process for obtaining solid, sustained-release pharmaceutical forms. - Google Patents

Process for obtaining solid, sustained-release pharmaceutical forms.

Info

Publication number
DZ964A1
DZ964A1 DZ860158A DZ860158A DZ964A1 DZ 964 A1 DZ964 A1 DZ 964A1 DZ 860158 A DZ860158 A DZ 860158A DZ 860158 A DZ860158 A DZ 860158A DZ 964 A1 DZ964 A1 DZ 964A1
Authority
DZ
Algeria
Prior art keywords
sustained
release pharmaceutical
pharmaceutical forms
drug
obtaining solid
Prior art date
Application number
DZ860158A
Other languages
French (fr)
Inventor
Rosa Martani
Le Elisabeth Huede
Jeanne Dumas
Original Assignee
Cortial
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortial filed Critical Cortial
Application granted granted Critical
Publication of DZ964A1 publication Critical patent/DZ964A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The process consists of making a granulate of a drug compsn., an anionic surfactant and a hydrophilic polymer in which the drug is an acid addn. salt of an organic abse or a quat. ammonium salt, with the condition that the organic base is not chlorofeniramin. Pref. the drug is an acid addn. salt of an organic amine, the surfactant is a sulpho-succinate and the polymer is a water-sol. ether of hydroxyalkyl cellulose.
DZ860158A 1985-07-26 1986-07-23 Process for obtaining solid, sustained-release pharmaceutical forms. DZ964A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8511575A FR2585246A1 (en) 1985-07-26 1985-07-26 PROCESS FOR OBTAINING SOLID PHARMACEUTICAL FORMS WITH PROLONGED RELEASE

Publications (1)

Publication Number Publication Date
DZ964A1 true DZ964A1 (en) 2004-09-13

Family

ID=9321740

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ860158A DZ964A1 (en) 1985-07-26 1986-07-23 Process for obtaining solid, sustained-release pharmaceutical forms.

Country Status (13)

Country Link
US (1) US4834965A (en)
EP (1) EP0214735B1 (en)
AT (1) ATE66599T1 (en)
AU (1) AU585377B2 (en)
CA (1) CA1304684C (en)
DE (1) DE3681099D1 (en)
DZ (1) DZ964A1 (en)
ES (1) ES2000555A6 (en)
FR (1) FR2585246A1 (en)
MA (1) MA20745A1 (en)
OA (1) OA08368A (en)
PT (1) PT83052B (en)
ZA (1) ZA865455B (en)

Families Citing this family (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058111T3 (en) * 1986-06-10 1994-11-01 Euro Celtique Sa COMPOSITION OF CONTROLLED RELEASE OF DIHYDROCODEIN.
ES2194832T3 (en) * 1987-10-16 2003-12-01 Elan Corp Plc FORMULATIONS OF DITIAZEM WITH CONTROLLED ABSORPTION.
WO1989009066A1 (en) * 1988-03-24 1989-10-05 Bukh Meditec A/S Controlled release composition
FR2630913A1 (en) * 1988-05-09 1989-11-10 Delalande Sa DILTIAZEM WATER SOLUBLE SALT (S) COMPRESSES WITH PROGRAMMED RELEASE AND METHOD OF MANUFACTURING THE SAME
NL8902338A (en) * 1988-09-20 1990-04-17 Glaxo Group Ltd PHARMACEUTICAL PREPARATIONS.
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
JP3623805B2 (en) * 1992-02-20 2005-02-23 ユーロセルテイツク・エス・アー Hydromorphone spheroid modified release formulation
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
DE4319649A1 (en) * 1993-03-18 1994-09-22 Asta Medica Ag Oral dosage forms containing flupirtine with controlled release of active ingredients
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
ATE243501T1 (en) * 1993-11-18 2003-07-15 Sirtex Medical Ltd CONTROLLED RELEASE PREPARATION
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (en) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 Manufacturing method and sustained release composition of pharmaceutical composition
US5419917A (en) * 1994-02-14 1995-05-30 Andrx Pharmaceuticals, Inc. Controlled release hydrogel formulation
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
WO1997037680A1 (en) * 1996-04-05 1997-10-16 The Board Of Trustees Of The University Of Illinois Macromolecular complexes for drug delivery
US6057367A (en) * 1996-08-30 2000-05-02 Duke University Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
US5935599A (en) * 1996-10-28 1999-08-10 The Board Of Trustees Of The University Of Illinois Polymer-associated liposomes for drug delivery and method of manufacturing the same
JP2001526228A (en) 1997-12-22 2001-12-18 ユーロ−セルティーク，エス．エイ． Opioid agonist / antagonist combination
RU2228180C2 (en) * 1997-12-22 2004-05-10 Эро-Селтик, С.А. Method for prevention abuse with opioid- -containing medicinal formulations
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DE19918325A1 (en) 1999-04-22 2000-10-26 Euro Celtique Sa Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20060034937A1 (en) * 1999-11-23 2006-02-16 Mahesh Patel Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
AP1665A (en) 2000-02-08 2006-09-22 Euro Celtique Sa Tamper-resistant oral opioid agonist formulations.
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6417237B1 (en) * 2000-06-08 2002-07-09 The Board Of Trustees Of The University Of Illinois Macromolecular drug complexes and compositions containing the same
DE10031043A1 (en) * 2000-06-26 2002-02-14 Bayer Ag Retarded preparations of quinolone antibiotics and process for their preparation
US6855721B1 (en) 2000-07-28 2005-02-15 Indevus Pharmaceuticals, Inc. Methods and compositions for alleviating stuttering
CN1525851A (en) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ Abuse-resistant controlled-release opioid dosage form
WO2003007802A2 (en) * 2001-07-18 2003-01-30 Euro-Celtique, S.A. Pharmaceutical combinations of oxycodone and naloxone
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US20030157168A1 (en) * 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
IL160222A0 (en) 2001-08-06 2004-07-25 Euro Celtique Sa Opioid agonist formulations with releasable and sequestered antagonist
SI2425825T1 (en) 2002-04-05 2017-05-31 Mundipharma Medical Cee Gmbh Pharmaceutical preparation containing oxycodone and naloxone
US20050020613A1 (en) * 2002-09-20 2005-01-27 Alpharma, Inc. Sustained release opioid formulations and method of use
US7815934B2 (en) * 2002-09-20 2010-10-19 Alpharma Pharmaceuticals, Llc Sequestering subunit and related compositions and methods
US20050137265A1 (en) * 2003-03-31 2005-06-23 Haley Eugene T. Rapidly dissolving metoclopramide solid oral dosage and method thereof
US20040192781A1 (en) * 2003-03-31 2004-09-30 Haley Eugene T. Method of administration for metoclopramide and pharmaceutical formulation therefor
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
US8906413B2 (en) 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
EP1694128A4 (en) * 2003-12-18 2007-04-18 Huntsman Spec Chem Corp Surfactant enhanced quick release pesticide granules
EP1744740A4 (en) 2004-04-27 2009-06-17 Medicinova Inc Phenoxyalkycarboxylic acid derivatives in the treatment of inflammatory diseases
EP1750710B1 (en) * 2004-05-14 2014-04-16 KNU-Industry Cooperation Foundation Neuroprotective properties of dextrorotatory morphinans
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
US9308176B2 (en) * 2004-10-15 2016-04-12 Supernus Pharmaceuticals, Inc Less abusable pharmaceutical preparations
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
KR20080028361A (en) * 2005-05-03 2008-03-31 뮤추얼 파마슈티컬 컴퍼니 아이엔씨. Quinine-containing controlled-release formulations
JP2009514884A (en) * 2005-11-04 2009-04-09 イーストマン ケミカル カンパニー Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
PT2719378T (en) 2006-06-19 2016-11-02 Alpharma Pharmaceuticals Llc Pharmaceutical compositions
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
US20110177133A1 (en) * 2008-07-07 2011-07-21 Michael Hopp Use of opioid antagonists for treating urinary retention
CA2750144C (en) 2008-12-31 2016-10-25 Upsher-Smith Laboratories, Inc. Opioid-containing oral pharmaceutical compositions and methods
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
SG174286A1 (en) 2009-03-10 2011-10-28 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
CA2773521C (en) 2009-09-17 2017-01-24 Upsher-Smith Laboratories, Inc. A sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US8962687B2 (en) 2012-12-05 2015-02-24 Medicinova, Inc. Method of treating liver disorders
US8835499B2 (en) 2011-12-08 2014-09-16 Medicinova, Inc. Method of treating non-alcoholic fatty liver disease and steatohepatitis
NZ716267A (en) 2013-07-23 2017-05-26 Euro Celtique Sa A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
JP6363192B2 (en) 2013-07-25 2018-07-25 メディシノバ・インコーポレイテッドＭｅｄｉｃｉＮｏｖａ， Ｉｎｃ． Methods for reducing blood levels of triglycerides, total cholesterol, and low density lipoprotein
CA2931547A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
US20150321989A1 (en) 2014-05-08 2015-11-12 Medicinova, Inc. Method of treating idiopathic pulmonary fibrosis
US9346754B2 (en) 2014-05-08 2016-05-24 Medicinova, Inc. Method of treating advanced non-alcoholic steatohepatitis
CN106470678A (en) 2014-06-02 2017-03-01 美迪诺亚公司 Suppression or the Fibrotic method for the treatment of
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CA2967826C (en) 2014-11-26 2024-01-16 Medicinova, Inc. A combination of ibudilast and riluzole and methods of using same
WO2017062997A1 (en) 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation
EP3544614A4 (en) 2016-11-28 2020-08-05 Lipocine Inc. Oral testosterone undecanoate therapy
CN117320701A (en) 2021-05-28 2023-12-29 美迪诺亚公司 Method for reducing synthesis of triglyceride in liver

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2802114A1 (en) * 1978-01-19 1979-07-26 Sandoz Ag Pharmaceuticals contg. aryl- and/or aryloxy-alkanolamine derivs. - with fatty alcohol mono:sulphate surfactant, useful as beta-blockers and antiarrhythmic agents
FR2523446A1 (en) * 1982-03-19 1983-09-23 Dietlin Francois Controlled release pharmaceutical compsns. - for oral admin. contg. konjak mannan(s) and surfactant
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
US4624848A (en) * 1984-05-10 1986-11-25 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release

Also Published As

Publication number Publication date
EP0214735A1 (en) 1987-03-18
EP0214735B1 (en) 1991-08-28
PT83052A (en) 1986-08-01
MA20745A1 (en) 1987-04-01
DE3681099D1 (en) 1991-10-02
ATE66599T1 (en) 1991-09-15
OA08368A (en) 1988-02-29
ZA865455B (en) 1987-03-25
US4834965A (en) 1989-05-30
AU585377B2 (en) 1989-06-15
AU6058386A (en) 1987-01-29
ES2000555A6 (en) 1988-03-01
CA1304684C (en) 1992-07-07
FR2585246A1 (en) 1987-01-30
PT83052B (en) 1988-07-01

Similar Documents

Publication Publication Date Title
DZ964A1 (en) Process for obtaining solid, sustained-release pharmaceutical forms.
DZ1923A1 (en) Salts of an anti-migraine derivative of indole, its production process and pharmaceutical composition containing it.
FR2599027B1 (en) DERIVATIVES OF TETRAHYDRONAPHTALENE AND INDANE, USE FOR THE MANUFACTURE OF PHARMACEUTICAL PREPARATIONS AND PROCESS FOR OBTAINING SAME.
PT82610B (en) PROCESS FOR THE PREPARATION OF THIAZOLIDINO-DIONAS HIPOGLICEMICAS
OA08871A (en) New thiazole derivatives active on the cholinergic system, process for obtaining them and pharmaceutical compositions containing them.
FR2629344B1 (en) CONTROLLED RELEASE PHARMACEUTICAL PREPARATION AND PROCESS FOR THE PRODUCTION THEREOF
DZ2786A1 (en) Pharmaceutical preparation of sildenafil for oral disintegration and process for its production.
BR8803908A (en) PROCESS FOR THE PREPARATION OF A 1-OLEPHINE POLYMER
OA08192A (en) New process for obtaining sustained-release pharmaceutical forms.
PT81091B (en) PROCESS FOR THE PREPARATION OF CONSTANT LIBERATION TABLETS
EP0357565A3 (en) New process for the synthesis of the levodopa
BR8803697A (en) PROCESS FOR THE PREPARATION OF A FUNCTIONALIZED AND HYDROGENATED POLYMER
PT92789A (en) PROCESS FOR THE PREPARATION OF A POLYMER BASED ON VINYL CHLORIDE
IT8922135A0 (en) PROCESS FOR THE PRODUCTION OF AQUEOUS SOLUTIONS OF ANTI-FOILING AGENTS AND SOLUTIONS OBTAINED SO
AT368502B (en) METHOD FOR THE PRODUCTION OF NEW 1,3-DIHYDRO-HETEROARYL SPIRO (ISOBENZOFURAN) S AND ITS OPTICAL ANTIPODES AND PHARMACEUTICALLY COMPATIBLE ACID ADDITION SALTS
OA06469A (en) Process for obtaining amino acids from protein hydrolysates.
FR2627986B1 (en) PHARMACEUTICAL COMPOSITION BASED ON 1,2,3,9-TETRAHYDRO-9-METHYL-3 - ((2-METHYL-1H-IMIDAZOL-1-YL) METHYL) -4H-CARBAZOL-4-ONE OR ONE OF THEM ITS SALTS AND DEXAMETHASONE, PROCESS FOR THE PREPARATION THEREOF AND USES THEREOF
DE58908990D1 (en) Synthetic vaccine against foot-and-mouth disease and process for its manufacture.
IT1165058B (en) PROCESS FOR THE PREPARATION OF ALFA SCRATCHED POLYMERS, ALFA 'DISPLACED BETA-PROPIOLATTONS ON ISOBUTYLENE AND TRIEN-BASED COPOLERS
DZ2757A1 (en) Process for the preparation of hydroxamic acids.
FR2713620B1 (en) Process for the preparation of an iridium-based solution, solution obtained and use thereof as a catalyst.
FR2583419B1 (en) PROCESS FOR THE PREPARATION OF 2-BROMO-A-ERGOCRYPTINE AND ITS ADDED SALTS OF ACIDS.
FR2708611B1 (en) Codeine salt of 2- (3-benzoylphenyl) propionic acid, process for obtaining it and pharmaceutical compositions containing it.
FR2709961B1 (en) Pharmaceutical form molded for oral administration based on acetylsalicylic acid or its salts and its manufacturing process.
BR8706576A (en) PROCESS FOR THE PREPARATION OF IMIDAS, PROCESS FOR THE PREPARATION OF POLYMERS AND SUBSTANCE MIXTURE